3Bohm M,Lippoldt A,Wienen W,et al.Reduction of cardiochypertrophy in TGR (mREN 2) 27 by angiotensin Ⅱ receptor blockade[J].Mol Cell Biochem、 1996,163/164; 217.
4Hauel NH,Ries UJ,Van Meel JCA,et al.Chemistry of telmisartan.a highly lipophilic angiotensin Ⅱ antagonist with a long duration of acyion[S].1st International Symposium on Angiotensin Ⅱ Antagonism,London,1997,16.
1[1]Goodriend T L,Elliott ME,Catt K J.Angiotensin receptors and their antagonists.NEngl J Med,1996,334:1649～1654.
2[3]Myers MG.Trough-to-peak ratio and 24-hour blood pressure control:Methodolgic issue,A M J Hypertens,1995,8:214～219.
3[5]WHO-ISH Hypertension Guidelines Committee,1999 World Health Organization-International Society of Hypertension guide-lines for the management of hypertension.J Hypertension,1999,17(2):151～185.
4[6]Hauel N H,Ries UJ,van Meel JCA,et al.Chemistry of telmisartan,a highly lipophilic angiotensinⅡ antagonist with a long duration of action,Presented at:Ist International Symposium on AnigotensinⅡ Antagonism,London,UK 28 september-1 October 1997,AbstractP16.
5[7]Wienen W,Hauel N,van Meel J C A,et al.pharmacological characterization of the novel nonpeptide angiotensin Ⅱ receptor antagonist,BIBR 277.Br J Pharmacol,1993,110:245～252.
6[9]Smith DHG,Neutel JM,Morgenstern P.Once-daily telmisartan compared with enalapril in the treatment of hypertension.Adv Ther,1998,15:229～240.
